Evidence map›Paper›PMID 22171041›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

The BMP coreceptor RGMb promotes while the endogenous BMP antagonist noggin reduces neurite outgrowth and peripheral nerve regeneration by modulating BMP signaling.

Chi H E Ma, Gary J Brenner, Takao Omura, Omar A Samad, Michael Costigan, Perrine Inquimbert, Vera Niederkofler, Rishard Salie, Chia Chi Sun, Herbert Y Lin and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. A small molecule M1 promotes optic nerve regeneration to restore target-specific neural activity and visual function.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.Frontiers in cell and developmental biology · 2020
    Review
  15. Article
  16. The Cofilin/Limk1 Pathway Controls the Growth Rate of Both Developing and Regenerating Motor Axons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Chi H E MaF.M. Kirby Neurobiology Center, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA.
Gary J Brenner
Takao Omura
Omar A Samad
Michael Costigan
Perrine Inquimbert
Vera Niederkofler
Rishard Salie
Chia Chi Sun
Herbert Y Lin
Silvia Arber
Giovanni Coppola
Clifford J Woolf
Tarek A Samad
Harvard University · USCenter for Systems Biology · USUniversity of Basel · CHYale University · USPain and Rehabilitation Medicine · USPfizer (United States) · USUniversity of California, Los Angeles · US

Funding

ALTERED SENSIBILITY FOLLOWING PERIPHERAL NERVE DAMAGER01NS038253 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WOOLF, CLIFFORD J · 1999 to 2017
$8.2M
Microglia, Complement, and PainR01DE017821 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI WOOLF, CLIFFORD J · 2006 to 2010
$2.4M
NMDA Receptor Phosphorylation and Trafficking after PainK08NS044139 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BRENNER, GARY JAY · 2002 to 2006
$853k
NIDCR NIH HHS R01 DE017821NINDS NIH HHS K08 NS044139NINDS NIH HHS NS038253NINDS NIH HHS NS044139NINDS NIH HHS R01 NS038253PHS HHS RDE017821A
6 · The paper itself

Abstract

Repulsive guidance molecule b (RGMb) is a bone morphogenetic protein (BMP) coreceptor and sensitizer of BMP signaling, highly expressed in adult dorsal root ganglion (DRG) sensory neurons. We used a murine RGMb knock-out to gain insight into the physiological role of RGMb in the DRG, and address whether RGMb-mediated modulation of BMP signaling influences sensory axon regeneration. No evidence for altered development of the PNS and CNS was detected in RGMb(-/-) mice. However, both cultured neonatal whole DRG explants and dissociated DRG neurons from RGMb(-/-) mice exhibited significantly fewer and shorter neurites than those from wild-type littermates, a phenomenon that could be fully rescued by BMP-2. Moreover, Noggin, an endogenous BMP signaling antagonist, inhibited neurite outgrowth in wild-type DRG explants from naive as well as nerve injury-preconditioned mice. Noggin is downregulated in the DRG after nerve injury, and its expression is highly correlated and inversely associated with the known regeneration-associated genes, which are induced in the DRG by peripheral axonal injury. We show that diminished BMP signaling in vivo, achieved either through RGMb deletion or BMP inhibition with Noggin, retarded early axonal regeneration after sciatic nerve crush injury. Our data suggest a positive modulatory contribution of RGMb and BMP signaling to neurite extension in vitro and early axonal regrowth after nerve injury in vivo and a negative effect of Noggin.

Indexed as

AnimalsBone Morphogenetic ProteinsCarrier ProteinsCell Adhesion Molecules, NeuronalCells, CulturedGanglia, SpinalGPI-Linked ProteinsMiceMice, KnockoutNerve CrushNerve RegenerationNerve Tissue ProteinsNeuritesNeuronsNoggin ProteinPhosphorylationBone Morphogenetic ProteinsCarrier ProteinsCell Adhesion Molecules, NeuronalGPI-Linked ProteinsNerve Tissue ProteinsNoggin ProteinRgmb protein, mouse

Identifiers

PMID22171041
PMCPMC3243947
OpenAlexW1971219322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.